VERA•benzinga•
JP Morgan Maintains Overweight on Vera Therapeutics, Raises Price Target to $75
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 5, 2024 by benzinga